As of 2024-12-14, the Intrinsic Value of Medifast Inc (MED) is
80.91 USD. This Medifast valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 19.16 USD, the upside of Medifast Inc is
322.30%.
The range of the Intrinsic Value is 70.43 - 96.55 USD
80.91 USD
Intrinsic Value
Medifast Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
70.43 - 96.55 |
80.91 |
322.3% |
| DCF (Growth 10y) |
76.67 - 103.03 |
87.28 |
355.5% |
| DCF (EBITDA 5y) |
56.13 - 81.14 |
62.70 |
227.2% |
| DCF (EBITDA 10y) |
65.57 - 90.50 |
72.64 |
279.1% |
| Fair Value |
11.77 - 11.77 |
11.77 |
-38.58% |
| P/E |
15.78 - 138.31 |
62.52 |
226.3% |
| EV/EBITDA |
21.83 - 101.99 |
56.06 |
192.6% |
| EPV |
167.95 - 206.95 |
187.45 |
878.3% |
| DDM - Stable |
4.18 - 8.38 |
6.28 |
-67.2% |
| DDM - Multi |
50.32 - 68.63 |
57.54 |
200.3% |
Medifast Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
209.61 |
| Beta |
-0.54 |
| Outstanding shares (mil) |
10.94 |
| Enterprise Value (mil) |
94.30 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.70% |
| Cost of Debt |
5.00% |
| WACC |
6.78% |